Comis Symposium – Fall 2022
Robert L. Comis, MD Translational Science Symposium
Real World Data (RWD)
October 26, 2022
Washington, DC
A highlight of the ECOG-ACRIN Group Meeting
This symposium is named for the ECOG-ACRIN Cancer Research Group’s late Group Co-Chair Robert L. Comis, MD (pictured at left). The potential of translational science to advance cancer diagnosis, prevention, and treatment was a guiding passion for Dr. Comis, and the symposium honors him in this way. Learn more about Dr. Comis here.
AGENDA
WELCOME AND SUMMARY OF SYMPOSIUM
Peter J. O’Dwyer, MD and Mitchell D. Schnall, MD, PhD
ECOG-ACRIN Group Co-Chairs, University of Pennsylvania
VALUE PROPOSITION
The Value of RWD and Practical Implementation
Donna R. Rivera, PhamD, MS
US Food and Drug Administration
Pharmaceutical Company Perspective on RWD
Martina von Meyenn, PhD
Roche
Data Sources and Applications for Real World Evidence in Oncology
Ronac Mamtani, MD, MSCE
University of Pennsylvania
ROADMAP FOR IMPLEMENTATION
Looking Beyond Clinical Trials to Inform their Design and Interpretation
David E. Gerber, MD
UT Southwestern Medical Center
Real World Data; Reaching Inaccessible Populations and Casting a Broad Net
Otis W. Brawley, MD
Johns Hopkins University
Innovating Evidence Generation - An Industry Perspective
Marlene Thomas, PhD
Roche
Considerations for Use of Real World Data in Extrenal Controls and Novel Trial Designs
Meghna Samant, PhD
Flatiron Health
PANEL DISCUSSION
Peter J. O’Dwyer, MD and Mitchell D. Schnall, MD, PhD
ECOG-ACRIN, University of Pennsylvania
CLOSING REMARKS
Mitchell D. Schnall, MD, PhD
ECOG-ACRIN, University of Pennsylvania
Download the printed program to read speaker bios.
